These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34584438)

  • 21. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irreversible electroporation and adjuvant chemoradiotherapy for locally advanced pancreatic carcinoma.
    Xu K; Chen Y; Su J; Su M; Yan L
    J Cancer Res Ther; 2020; 16(2):280-285. PubMed ID: 32474514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of irreversible electroporation ablation combined with natural killer cells in treating locally advanced pancreatic cancer.
    Pan Q; Hu C; Fan Y; Wang Y; Li R; Hu X
    J BUON; 2020; 25(3):1643-1649. PubMed ID: 32862617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Efficacy of Irreversible Electroporation in Locally Advanced Pancreatic Cancer: An Evaluation from a Surgeon's Perspective.
    Shen J; Pan P; Hu X; Zhao J; Wu H
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis.
    Sugumar K; Hurtado A; Naik I; Hue JJ; Rothermel LD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
    HPB (Oxford); 2022 May; 24(5):586-595. PubMed ID: 35000842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial Clinical Experience in Japan.
    Sugimoto K; Moriyasu F; Tsuchiya T; Nagakawa Y; Hosokawa Y; Saito K; Tsuchida A; Itoi T
    Intern Med; 2018 Nov; 57(22):3225-3231. PubMed ID: 29984761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
    Ma Y; Xing Y; Li H; Liang B; Li R; Li J; Li Z; Lin M; Niu L
    J Oncol; 2022; 2022():3523769. PubMed ID: 35747123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma.
    Leen E; Picard J; Stebbing J; Abel M; Dhillon T; Wasan H
    J Gastrointest Oncol; 2018 Apr; 9(2):275-281. PubMed ID: 29755766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry.
    Holland MM; Bhutiani N; Kruse EJ; Weiss MJ; Christein JD; White RR; Huang KW; Martin RCG
    HPB (Oxford); 2019 Aug; 21(8):1024-1031. PubMed ID: 30737097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer.
    Moris D; Machairas N; Tsilimigras DI; Prodromidou A; Ejaz A; Weiss M; Hasemaki N; Felekouras E; Pawlik TM
    Ann Surg Oncol; 2019 Jun; 26(6):1657-1668. PubMed ID: 30843163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
    Månsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
    Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irreversible electroporation of locally advanced pancreatic cancer.
    Kwon W; Thomas A; Kluger MD
    Semin Oncol; 2021 Feb; 48(1):84-94. PubMed ID: 33648735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Prediction Tool Based on Large Cohorts to Determine the Cancer-Specific Survival Probability of Patients With Locally Advanced Pancreatic Cancer After Irreversible Electroporation Treatment.
    He C; Huang X; Zhang Y; Lin X; Li S
    Front Oncol; 2020; 10():952. PubMed ID: 32695671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial.
    Rai ZL; Ranieri V; Palmer DH; Littler P; Ghaneh P; Gurusamy K; Manas D; Pizzo E; Psarelli EE; Gilmore R; Peddu P; Bartlett DC; de Liguori Carino N; Davidson BR
    BMJ Open; 2022 May; 12(5):e050166. PubMed ID: 35551086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer.
    Lafranceschina S; Brunetti O; Delvecchio A; Conticchio M; Ammendola M; Currò G; Piardi T; de'Angelis N; Silvestris N; Memeo R
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31684186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible electroporation for locally advanced pancreatic cancer through a minimally invasive surgery supported by laparoscopic ultrasound.
    Tartaglia E; Fabozzi M; Rizzuto A; Settembre A; Abete R; Guerriero L; Favoriti P; Cuccurullo D; Corcione F
    Int J Surg Case Rep; 2018; 42():290-294. PubMed ID: 29335228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
    Ong DY; Pua U
    Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irreversible Electroporation (IRE) in Locally Advanced Pancreatic Cancer: A Review of Current Clinical Outcomes, Mechanism of Action and Opportunities for Synergistic Therapy.
    Rai ZL; Feakins R; Pallett LJ; Manas D; Davidson BR
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.
    Lin M; Alnaggar M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Oncotarget; 2017 Nov; 8(60):101795-101807. PubMed ID: 29254205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.